0001472343-15-000123.txt : 20151118 0001472343-15-000123.hdr.sgml : 20151118 20151118162202 ACCESSION NUMBER: 0001472343-15-000123 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20151112 FILED AS OF DATE: 20151118 DATE AS OF CHANGE: 20151118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Roka BioScience, Inc. CENTRAL INDEX KEY: 0001472343 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 270881542 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 INDEPENDENCE BOULEVARD CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-605-4700 MAIL ADDRESS: STREET 1: 20 INDEPENDENCE BOULEVARD CITY: WARREN STATE: NJ ZIP: 07059 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boesgaard Lars CENTRAL INDEX KEY: 0001403893 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36538 FILM NUMBER: 151241038 MAIL ADDRESS: STREET 1: C/O ROKA BIOSCIENCE, INC. STREET 2: 20 INDEPENDENCE BOULEVARD CITY: WARREN STATE: NJ ZIP: 07059 3 1 wf-form3_144788171148976.xml FORM 3 X0206 3 2015-11-12 0 0001472343 Roka BioScience, Inc. ROKA 0001403893 Boesgaard Lars 20 INDEPENDENCE BLVD WARREN NJ 07059 0 1 0 0 Vice President, CFO Common Stock 53792 D Stock Option (right to buy) 1.766 2011-04-02 2020-04-01 Common Stock 6757.0 D Stock Option (right to buy) 1.766 2011-06-30 2020-06-29 Common Stock 4565.0 D Stock Option (right to buy) 3.643 2013-02-01 2022-01-31 Common Stock 20380.0 D Stock Option (right to buy) 0.993 2014-01-01 2022-12-31 Common Stock 9963.0 D Stock Option (right to buy) 4.36 2016-01-02 2025-01-01 Common Stock 23000.0 D Such stock options vested 25% on April 2, 2011 and in 1/36th increments on a monthly basis beginning one month after that. As of the date of this Form 3, all such stock options are vested. The stock options have a term of ten years. Such stock options vested 25% on June 30, 2011 and in 1/36th increments on a monthly basis beginning one month after that. As of the date of this Form 3, all such stock options are vested. The stock options have a term of ten years. Such stock options vested 25% on February 1, 2013 and vest in 1/36th increments on a monthly basis beginning one month after that. The stock options have a term of ten years. Such stock options vested 25% on January 1, 2014 and vest in 1/36th increments on a monthly basis beginning one month after that. The stock options have a term of ten years. Such stock options vest 25% on January 2, 2016 and in 1/36th increments on a monthly basis beginning one month after that. The stock options have a term of ten years. Exhibit 24.1 - Power of Attorney /s/ Corey Swanson, attorney in fact 2015-11-18 EX-24 2 ex-24.htm EX24BOESGAARD

POWER OF ATTORNEY

    Know all by these presents that the undersigned hereby constitutes and appoints each of Paul Thomas, Lars Boesgaard, and Corey Swanson, or either of them signing singly, and with full power of substitution, the undersigned's true and lawful attorney in fact to:

(1)    if necessary, prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC;

(2)    execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of Roka Bioscience, Inc. (the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; and

(3)        do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority.

    The undersigned hereby grants to each such attorney in fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney in fact, or such attorney in fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys in fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

    This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys in fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 17th day of November, 2015.


/s/ Lars Boesgaard
Signature

Lars Boesgaard
Print Name